These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32056332)

  • 1. Gene expression profiling of primary vitreoretinal lymphoma.
    Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
    Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
    Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
    Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
    Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
    Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes.
    Xie Z; Qin Y; Chen X; Yang S; Yang J; Gui L; Liu P; He X; Zhou S; Zhang C; Tang L; Shi Y
    Target Oncol; 2024 May; 19(3):383-400. PubMed ID: 38643457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram for predicting survival of patients with diffuse large B-cell lymphoma.
    Fujii K; Inagaki A; Masaki A; Sugiura M; Suzuki T; Ishida T; Kusumoto S; Iida S; Inagaki H
    Ann Hematol; 2024 Jun; 103(6):2041-2050. PubMed ID: 38411628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
    Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
    Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System.
    DO J; Yenwongfai LN; DO SI; Kim SW; Na K
    Anticancer Res; 2024 Jul; 44(7):2953-2960. PubMed ID: 38925823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.
    Ramkumar HL; Shen DF; Tuo J; Braziel RM; Coupland SE; Smith JR; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1541-8. PubMed ID: 22628023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
    Kersten MJ; Kraan W; Doorduijn J; Bromberg J; Lam K; Kluin PM; van der Holt BJ; Spaargaren M; Pals ST
    Blood Cancer J; 2014 Dec; 4(12):e266. PubMed ID: 25501023
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
    Kim PM; Nejati R; Lu P; Thakkar D; Mackrides N; Dupoux V; Nakhoda S; Baldwin DA; Pei J; Dave SS; Wang YL; Wasik MA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37730436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma.
    Yoshifuji K; Sadato D; Toya T; Motomura Y; Hirama C; Takase H; Yamamoto K; Harada Y; Mori T; Nagao T
    Haematologica; 2024 Jun; ():. PubMed ID: 38841798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated
    Liu Y; Ma X; Wu X; Hou X; Jin W; Fu L; Xun X; Yu Y; Shen Z
    Leuk Lymphoma; 2024 May; ():1-11. PubMed ID: 38775302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma.
    Brown NA; Rao RC; Betz BL
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients.
    Chen K; Qin H; Li X; Zhou X; Ma J; Guan M
    Clin Chim Acta; 2024 Jul; 561():119827. PubMed ID: 38909978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Large B-cell Lymphomas of Immune-Privileged Sites.
    Roschewski M; Phelan JD; Jaffe ES
    Blood; 2024 Apr; ():. PubMed ID: 38635786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Bacillary Layer Detachment During the Disease Course of Primary Vitreoretinal Lymphoma.
    Casalino G; Malerba A; Fabris S; Bolli N; Croci GA; Pellegrini M; Rossi FG; Mapelli C; Viola F
    Ocul Immunol Inflamm; 2024 Jun; ():1-6. PubMed ID: 38838286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice.
    Visco C; Tanasi I; Quaglia FM; Ferrarini I; Fraenza C; Krampera M
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050534
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
    Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.